Bartox Consulting LTD

• study design including amendments to standard (ich/oecd/epa guideline) designs based on expected pharmacological/class-based considerations or to follow up previous equivocal findingsselection of suitable laboratories for study placement • study monitoring to ensure compliance with glp and early availability of interim findings and allowing adaption of pre-clinical programme if findings so require • data review and interpretation, including a detailed understanding of procedures, and their inherent limitations, permitting expert insight into the validity, strength and accuracy of the conclusions • report writing or peer review • integration of data from 2 or more sources to give overall conclusion • assistance with reach dataset summaries